Show simple item record

dc.contributor.authorBalasegaram, M
dc.contributor.authorKolb, P
dc.contributor.authorMcKew, J
dc.contributor.authorMenon, J
dc.contributor.authorOlliaro, P
dc.contributor.authorSablinski, T
dc.contributor.authorThomas, Z
dc.contributor.authorTodd, MH
dc.contributor.authorTorreele, E
dc.contributor.authorWilbanks, J
dc.date.accessioned2017-04-27T14:56:30Z
dc.date.available2017-04-27T14:56:30Z
dc.date.issued2017-04-18
dc.date.submitted2017-04-24
dc.identifier.citationAn Open Source Pharma Roadmap. 2017, 14 (4):e1002276 PLoS Med.en
dc.identifier.issn1549-1676
dc.identifier.pmid28419094
dc.identifier.doi10.1371/journal.pmed.1002276
dc.identifier.urihttp://hdl.handle.net/10144/618903
dc.description.abstractIn an Essay, Matthew Todd and colleagues discuss an open source approach to drug development.
dc.language.isoenen
dc.publisherPublic Library of Scienceen
dc.rightsPublished by Public Library of Science, [url]http://medicine.plosjournals.org/[/url] Archived on this site by Open Access permissionen
dc.titleAn Open Source Pharma Roadmapen
dc.identifier.journalPLoS Medicineen
refterms.dateFOA2019-03-04T13:21:32Z
html.description.abstractIn an Essay, Matthew Todd and colleagues discuss an open source approach to drug development.


Files in this item

Thumbnail
Name:
Balasegaram M et al - 2017 - An ...
Size:
460.5Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record